Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezogabine PK and Safety in Pediatric Epilepsy
NCT01494584Phase 2Terminated
- Sponsor
- GSK
- Start
- Jul 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of retigabine in focal onset seizure, Lennox-Gastaut syndrome (LGS), sponsored by GSK. Started Jul 2012; status: terminated.
02
Drugs
retigabine
03
Conditions
focal onset seizureLennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT01494584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494584.